Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare
Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.
Earlier this year, Ecolab’s Bioquell HPV-AQ 35% hydrogen peroxide disinfectant received an approval opinion from the European Chemicals Agency (ECHA) Biocidal Products Committee (BPC) for a BPR EU (Union) Authorisation.
We are pleased to communicate that the approval has been officially published in the Official Journal of the European Union and thus written into European law, with Bioquell HPV-AQ given the approval number EU-0027469-0000.
Ecolab’s Bioquell HPV-AQ is authorized for use in all territories of the European Union and the European Economic Area. Recognition of the authorization in Switzerland has also been requested and is anticipated imminently.
The authorization supports the use of Bioquell HPV-AQ in applications under:
The authorization covers the use of the product with Bioquell vaporization systems in small enclosures (0.25m3 to 4m3) and in large enclosures (>4m3), with efficacy claims against the following groups of microbiological organisms:
The comprehensive Union Authorisation for Bioquell HPV-AQ has been designed to ensure that the vast majority, if not all, of our existing customer processes and use scenarios are covered under the authorization.
Ecolab recommends that users review all disinfectant products within their facility and speak to their suppliers, to ensure their use scenarios for those products will be covered by the supplier’s BPR application.
Should you have any further questions or queries, please contact your Ecolab representative.